Methods and compositions for cancer treatment
US-2024424094-A1 · Dec 26, 2024 · US
Coronaviridae, e.g. avian infectious bronchitis virus
Coronaviridae, e.g. avian infectious bronchitis virus · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/165 |
| Official title | Coronaviridae, e.g. avian infectious bronchitis virus |
| Display label | Coronaviridae, e.g. avian infectious bronchitis virus |
| Total patents | 167 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 24 |
| 2022 | 22 |
| 2023 | 41 |
| 2024 | 32 |
| 2025 | 19 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Polynucleotide encoding trimeric S1-CD40L fusion protein immunogen against middle east respiratory syndrome-corona virus
US-11529411-B2 · Dec 20, 2022 · US
Vaccine generation
US-11529153-B2 · Dec 20, 2022 · US
Stable coronavirus proteins and vaccine compositions thereof
US-2022325279-A1 · Oct 13, 2022 · US
IMMUNOGENIC AND VACCINE COMPOSITIONS AGAINST SARS-CoV-2
US-2022323574-A1 · Oct 13, 2022 · US
Immunogenic and vaccine compositions against SARS-CoV-2
US-11376320-B2 · Jul 5, 2022 · US
Neutralizing vaccines against human coronavirus
US-2022160822-A1 · May 26, 2022 · US
Methods for producing and using IgY antibodies targeting the middle east respiratory syndrome coronavirus spike protein to treat or prevent MERS-CoV infection
US-11319382-B1 · May 3, 2022 · US
Mers coronavirus vaccine
US-2021401971-A1 · Dec 30, 2021 · US
Rapid assay for detection of SARS-CoV-2 antibodies
US-11175293-B1 · Nov 16, 2021 · US
RNA Replicon Encoding a Stabilized Corona Virus Spike Protein
US-2021347828-A1 · Nov 11, 2021 · US
SARS-CoV-2 Vaccines
US-2021346492-A1 · Nov 11, 2021 · US
Sars-cov-2 n protein and methods of use
US-2021340189-A1 · Nov 4, 2021 · US
Vaccine Compositions For Preventing Coronavirus Disease
US-2021338804-A1 · Nov 4, 2021 · US
MERS-CoV vaccine with trimeric S1-CD40L fusion protein
US-11154612-B2 · Oct 26, 2021 · US
Compositions and methods for drug delivery and treating viral infections
US-2021317170-A1 · Oct 14, 2021 · US
MERS coronavirus vaccine
US-11141476-B2 · Oct 12, 2021 · US
IMMUNOGENIC COMPOSITION AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
US-2021308257-A1 · Oct 7, 2021 · US
Sars-cov-2 surrogate virus neutralization assay test kit
US-2021302434-A1 · Sep 30, 2021 · US
Anti COVID-19 Therapies targeting nucleocapsid and spike proteins
US-2021283245-A1 · Sep 16, 2021 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/165?
- CPC C07K14/165 is the Cooperative Patent Classification code for “Coronaviridae, e.g. avian infectious bronchitis virus.”
- How many patents are filed under CPC C07K14/165 (Coronaviridae, e.g. avian infectious bronchitis virus)?
- Our database includes 167 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/165 growing?
- Publication counts under this code: 32 in 2024 vs 19 in 2025 (latest complete years).